Tripep drug ready for study on HIV patients in Thailand
The Swedish biotechnology company Tripep AB, which is focusing on HIV therapy, has completed the pre-clinical safety evaluation studies on the company’s new anti-HIV candidate drug alpha-HGA necessary for the …
Tripep drug ready for study on HIV patients in Thailand Read More
